Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Contactin-associated protein-like 4 (CNTNAP4) is a transmembrane protein of the neurexin superfamily that functions primarily as a cell adhesion molecule and receptor in the vertebrate nervous system[2][3][7]. It is characterized by multiple functional domains, including epidermal growth factor (EGF) repeats, laminin G domains, and other cell interaction motifs[2][3]. CNTNAP4 is involved in regulating synaptic development and neurotransmitter release, particularly affecting inhibitory (GABAergic) and dopaminergic signaling, and is implicated in the proper formation and function of neural circuits[1][3][7]. Pathogenic variations or dysregulation of this protein are associated with autism spectrum disorder, epilepsy, some psychiatric illnesses, and potentially bone developmental syndromes due to its interaction with ligands such as Neural EGFL-like 1 (Nell-1)[1][3][6]. As a synaptic cell adhesion molecule and emerging receptor, it represents a target of interest for neuropsychiatric and developmental research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Contactin-associated protein-like 4 (CNTNAP4).